Laparoscopic Devices Market Poised to Garner Maximum Revenues During 2021 – 2028: Grand View Research Inc.

 Laparoscopic Devices Market Growth & Trends

The global laparoscopic devices market size is anticipated to reach USD 10.8 billion by 2028, expanding at a CAGR of 6.7%, according to a new report by Grand View Research, Inc. Increasing number of bariatric surgeries being performed and adoption of minimally invasive procedures are anticipated to boost the market growth.

According to the American Society for Metabolic and Bariatric Surgery (ASMBS), bariatric surgery is performed when a patient is suffering from obesity and they are not able to lose weight. Thus, growing cases of obesity are contributing to market growth. Increasing preference by surgeons for laparoscopic surgery owing to the benefits, such as small incisions, less healing time, and short hospital stay, is also driving the market.

Technological advancements are further expected to propel market growth. For instance, Medtronic’s LigaSure device is designed to deliver a specific combination of energy and pressure to create consistent seal within its applications. It provides unique combination of energy and pressure to create vessel fusion. Stryker laparoscopes had a combination of high-quality sapphires and rod lens technology used for superior transformation and excellent recognition to maximize image quality during surgical procedures.

Request a free sample copy or view report summary: Laparoscopic Devices Market Report

Laparoscopic Devices Market Report Highlights

• Energy systems led the market in 2018 due to the favorable reimbursement policies and new product launches, such as Olympus Corporation launched THUNDERBEAT, which is safe and versatile
• Bariatric surgery is projected to be the fastest-growing application segment owing to increasing cases of obesity. Moreover, these surgeries offer painless weight reduction and require shorter hospital stay
• North America was the dominant regional market in 2018 owing to higher adoption of minimally invasive surgeries and increased incidence of gallstones

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laparoscopic-devices-market

Laparoscopic Devices Market Segmentation

Grand View Research has segmented the global laparoscopic devices market on the basis of product, application, end-use, and region:

Laparoscopic Devices Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Trocars
• Energy Systems
• Closure Devices
• Suction / Irrigation Devices
• Insufflation Devices
• Laparoscopes
• Hand Access Instruments
• Robot-assisted System

Laparoscopic Devices Application Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Bariatric Surgery
• Colorectal Surgery
• General Surgery
• Gynecological Surgery
• Urological Surgery
• Others

Laparoscopic Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinic
• Ambulatory

Laparoscopic Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Qatar

List of Key Players of the Laparoscopic Devices Market

• Medtronic
• Stryker Corporation
• Karl Storz SE & CO. Kg
• Johnson and Johnson
• Olympus Corporation
• CONMED Corporation
• Braun Melsungen AG
• The Cooper Companies Inc.
• Richard Wolf GmbH
• Microline Surgical
• BD
• Welfare Medical Ltd.
• DEAM
• Intuitive Surgical
• Shenzen Mindray Bio Medical Electronics Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Printed Surgical Models Market Expected to Deliver Dynamic Progression By 2028

 3D Printed Surgical Models Market Growth & Trends

The global 3D printed surgical models market size is expected to reach USD 1.1 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.6% from 2021 to 2028. This growth can be attributed to the increasing prevalence of chronic disorders, the rising number of surgical procedures, and the growing need for customized healthcare products. Moreover, the growing use of 3D printing in the healthcare industry is also anticipated to positively impact the market.

The COVID-19 pandemic and the subsequent economic slowdown severely impacted the market. This can be attributed to delays in elective and/or non-emergency surgeries resulting in reduced demand for products and services Furthermore, the shutdown of market players’ vendors and customers coupled with reduced client investments also contributed towards a decline in market players’ revenue. Nonetheless, Materialise medical segment reported a nearly 3.7% increase in its Q1 2021 revenue when compared to the same period in 2020, thereby indicating market recovery from the impact of COVID-19 in the next few years.

According to a report by SME, in 2017, anatomical models accounted for nearly 47% of medical 3D printing in terms of application, making it the second most frequently used application field while surgical instruments and cutting guides accounted for nearly 39% of application scope. Thus, indicating a high demand for 3D printed surgical models in the medical industry.

Request a free sample copy or view report summary: 3D Printed Surgical Models Market Report

3D Printed Surgical Models Market Report Highlights

• The orthopedic surgery segment held a market share of more than 30% in 2020 owing to a high prevalence of orthopedic disorders such as arthritis coupled with a growing geriatric population across the globe
• The Fused Deposition Modeling (FDM) segment accounted for the largest market share of nearly 27.0% in 2020 due to high usage of FDM technology in the industry
• The plasticssegment accounted for the largest revenue share of 2020 and is anticipated to witness a CAGR of 15.7% over the forecast period due to high demand for advanced thermoplastic in the market
• North America dominated the market and accounted for the largest revenue share of over 34.0% in 2020 owing to the presence of favorable reimbursement policies and a high adoption rate for advanced medical technologies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-printed-surgical-models-market

3D Printed Surgical Models Market Segmentation

Grand View Research has segmented the global 3D printed surgical models market on the basis of specialty, technology, material, and region:

3D Printed Surgical Models Specialty Outlook (Revenue, USD Million, 2016 - 2028)

• Cardiac Surgery/Interventional Cardiology
  • Annuloplasty (mitral valve repair)
  • Repair Coronary Aneurysm
  • Replacement of Aortic Valve
  • Stent Insertion
  • Repair Congenital Heart Defects
• Gastroenterology Endoscopy of Esophageal
  • Endoscopy of Esophageal lesion
  • Splenectomy
• Neurosurgery
  • Repair Aneurysm
  • Transsphenoidal Excision of Pituitary Gland
  • Remove Brain Tumor
• Orthopedic Surgery
  • Repair Scoliosis
  • Repair Clavicle Fracture
  • Hip Repair
  • Repair Intervertebral Disc
  • Hip Replacement Revision
  • Repair Leg Fracture
  • Osteotomy
• Reconstructive Surgery
  • Facial Reconstruction
  • Hand Reconstruction
  • Breast Reconstruction
  • Mastoidectomy
  • Cleft Palate Correction
• Surgical oncology
  • Removal of Adrenal Tumor
  • Removal of Liver Tumor
  • Endoscopic Removal of Cardiac Lesion
  • Thoracic Removal of Lung Tumor
  • Removal of Renal Tumor
• Transplant Surgery
  • Cardiac Surgery/ Interventional Cardiology
  • Heart Transplant
  • Liver Transplant
  • Lung Transplant
  • Kidney Transplant

3D Printed Surgical Models Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Stereolithography (SLA)
• ColorJet Printing (CJP)
• MultiJet/PolyJet Printing
• Fused Deposition Modeling (FDM)
• Others

3D Printed Surgical Models Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Polymer
• Plastic
• Others

3D Printed Surgical Models Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Printed Surgical Models Market

• Stratasys Ltd.
• 3D Systems, Inc.
• Lazarus 3D, LLC
• Osteo3D
• Axial3D
• Onkos Surgical
• Formlabs
• Materialise NV
• 3D LifePrints U.K. Ltd.
• WhiteClouds Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Diabetes Devices Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2028

 Diabetes Devices Market Growth & Trends

The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Request a free sample copy or view report summary: Diabetes Devices Market Report

Diabetes Devices Market Report Highlights

• North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches
• By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate
• In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage
• In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements
• In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage
• In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices
• By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies
• By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment
• The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diabetes-devices-market

Diabetes Devices Market Segmentation

Grand View Research has segmented global diabetes devices market on the basis of type, distribution channel, end-use, and region:

Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• BGM Devices
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Homecare
• Diagnostic Centers

Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Czech Republic
  • Poland
  • Switzerland
  • Turkey
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Oman

List of Key Players of Diabetes Devices Market

• Medtronic plc
• Abbott Laboratories
• Hoffmann-La-Ltd.
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Ypsomed Holdings
• Companion Medical
• Sanofi
• Valeritas Holding Inc.
• Novo Nordisk
• Arkray, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Alopecia Market Size Is Expected To Reach USD 14.2 Billion by 2028

 Alopecia Market Growth & Trends

The global alopecia market size is expected to reach USD 14.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The strong presence of pipeline products and increasing approval for laser-based therapy to treat hair loss conditions are major factors anticipated to drive growth. Moreover, rising awareness among patients about alopecia and its treatments, increasing government initiatives, supportive regulations & laws, and improvements in healthcare infrastructure are factors expected to propel market growth over the forecast period.

Technological advancements in alopecia treatment are among the key drivers of this market. There are two FDA-approved therapeutics for alopecia-Rogaine and Propecia. There has been an increase in market penetration of generics after patent expiries of both drugs. However, the launch of several promising pipeline candidates over the forecast years such as Xeljanz (tofacitinib), Breezula (clascoterone), Jakafi (ruxolitinib), SM04554, and Lumigan (Bimatoprost) is expected to substantially drive the growth of the market in the near future.

The introduction of low-level laser therapy that helps stimulate hair growth is expected to increase the treatment rate among patients facing hair loss. In addition, the launch of laser caps, helmets, combs, and bands is also anticipated to boost the market growth. For instance, Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are some of the technologically advanced products available in the market.

Moreover, the increasing prevalence of diseases such as cancer, Polycystic Ovary Syndrome, and rheumatoid arthritis which are associated with hair loss is also expected to boost the treatment rate of hair loss in the near future. For instance, as per the U.S. Department of Health and Human Services, nearly 5 million women in the U.S. are affected by PCOS. Furthermore, according to the GBD database, the prevalence of PCOS in European countries, such as France, increased from 872,351 to 882,322 in 2018 & 2019, respectively, and in the U.K., the prevalence was found to be 1,134,082 to 1,142,498.

Market players are increasingly forming partnerships and licensing agreements to enhance their product capabilities and promote the outreach of their products. For instance, the iGrow laser system has a partnership with China Central Pharmaceuticals in China. China Central Pharmaceuticals holds exclusive distribution rights over Aspira in the country. Moreover, Capillus, LLC has collaborated with Svenson, a hair loss treatment clinic to expand the distribution of laser therapy caps in Europe and Asia Pacific region. The partnership with local players and service providers is expected to increase the adoption of innovative therapy for hair loss treatment.

Additionally, companies are actively participating in scientific conferences and conducting awareness campaigns for creating brand awareness. For instance, in February 2021, Hairmax welcomed Mary Brunetti as the brand ambassador to increase brand awareness about dealing with COVID-19-induced hair loss, as well as hereditary loss. Moreover, it plans to leverage the popularity of the brand ambassador to showcase its target market as to how its products can help regrow and revitalize their hair.

However, reimbursement remains one of the major challenges in this market. Since most of the treatment modalities are considered as not medically essential and are categorized as cosmetic procedures, the treatment for hair loss is generally not covered under insurance plans. Out-of-pocket expenses for alopecia treatment usually include prescription drug copays, frequent doctor visits, and co-insurance for procedures. Moreover, increasing adoption of substitutes, such as traditional medicines-Ayurvedic, Chinese, and herbal medications may hamper the growth of the market. Based on results from the GlaxoSmithKline plc sponsored survey, around 22.7% of the patients took Chinese medications for treating male androgenetic alopecia in South Korea followed by Taiwan with 22.0% patients.

Request a free sample copy or view report summary: Alopecia Market Report

Alopecia Market Report Highlights

• In 2020, the alopecia areata segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period
• Key late-stage pipeline candidates in the treatment of hair loss include: Xeljanz (tofacitinib), Breezula (clascoterone), and SM04554 are expected to fuel the growth in the coming years
• Alopecia universalis is anticipated to witness the fastest growth during the forecast period owing to the potential pipeline products, such as BNZ-1 (Bioniz Therapeutics), and stem cell educator therapy with minoxidil (Tianhe Stem Cell Biotechnologies, Inc.)
• North America was the largest market in 2020 mainly due to a high disease prevalence, rising consumer awareness, proactive government measures, technological advancements, and improved healthcare infrastructure
• Europe held the second-largest market share in 2020 given the high prevalence of AGA i.e., 80% and 50% in both the men and women of the region, respectively

Access Press Release@ https://www.grandviewresearch.com/press-release/global-alopecia-market

Alopecia Market Segmentation

Grand View Research has segmented the global alopecia market on the basis of treatment, disease type, gender, sales channel, end-use, and region:

Alopecia Disease Type Outlook (Revenue, USD Million, 2017 - 2028)

• Alopecia Areata
  • Male
  • Female
• Cicatricial Alopecia
  • Male
  • Female
• Traction Alopecia
  • Male
  • Female
• Alopecia Totalis
  • Male
  • Female
• Alopecia Universalis
  • Male
  • Female
• Androgenetic Alopecia
  • Male
  • Female
• Others
  • Male
  • Female

Alopecia Treatment Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceuticals
• Devices

Alopecia Gender Outlook (Revenue, USD Million, 2017 - 2028)

• Male
• Female

Alopecia Sales Channel Outlook (Revenue, USD Million, 2017 - 2028)

• Prescription
• OTC

Alopecia End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Homecare Settings
• Dermatology Clinics

Alopecia Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Alopecia Market

• Johnson & Johnson Services, Inc.
• Merck & Co. Inc.
• Cipla Limited
• Sun Pharmaceuticals Industries Ltd.
• Reddy's Laboratories Ltd.
• GlaxoSmithKline plc.
• Aurobindo Pharmas
• Mylan N.V. (Viatris Inc.)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Preterm Birth And PROM Testing Market Latest Innovations, Drivers and Industry Key Events 2021 – 2028: Grand View Research Inc.

 Preterm Birth And PROM Testing Market Growth & Trends

The global preterm birth and PROM testing market size is expected to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.0% from 2021 to 2028. Key factors that can be attributed to market growth are rising number of preterm births in developed and emerging economies, improving access to advanced neonatal and maternal care facilities, and introduction of new POC diagnostic products over the forecast period.

Preterm births are not specific to a particular geography and have been recognized as a worldwide concern. The risk of preterm births typically escalates with increasing average age of pregnant women. With growing awareness about preterm births and its consequence, the tendency of pregnant women to enroll for Premature Rupture of Membranes (PROM) testing during their pregnancy is anticipated to increase, for reassurance and monitoring of symptoms of preterm birth.

Point-of-Care (POC) diagnostics have drastically altered the methodology of testing in various fields. With the help of advanced technology, devices are able to assess analytes in a given sample. Companies are focusing on R&D to increase specificity and sensitivity of devices, which lowers the error rate. Hence, emphasis is being given to reducing sample size required for other medical testing.

Many low-income states like Bihar, Madhya Pradesh, Rajasthan, and Uttar Pradesh have low utilization of public healthcare services for female infants. Despite the availability of free healthcare services, only approximately 41% of admissions to the SNCUs are female infants. Hence, many states have banned gender revelation to the family before birth. India is the only large country where more female infants die than males. UNICEF plans to intervene by strengthening the health infrastructure, and reducing inequities of healthcare services, and improve healthcare outcomes.

Request a free sample copy or view report summary: Preterm Birth And PROM Testing Market Report

Preterm Birth And PROM Testing Market Report Highlights

• By test type, the ultrasound segment dominated the market in 2020, as it is one of the most preferred technologies for tracking fetal development and maternal health
• Techniques such as Placental Alpha-Microglobulin-1 (PAMG-1) are gaining prominence due to better reliability in predicting the risk of preterm births
• North America held the largest revenue share in 2020 owing to higher incidence of pregnancies in the above 35 years age group and well-developed infrastructure to manage high-risk pregnancies
• As per the American College of Obstetricians and Gynecologists (ACOG), in the U.S., nearly 12.0% of childbirths are preterm, which lead to higher hospitalization and treatment costs
• In Asia Pacific, the market is projected to witness the highest CAGR over the forecast period. This can be attributed to high population growth in countries such as India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-preterm-birth-prom-testing-market

Preterm Birth And PROM Testing Market Segmentation

Grand View Research has segmented the global preterm birth and PROM testing market on the basis of test type and region:

Preterm Birth And PROM Testing Type Outlook (Revenue, USD Million, 2016 - 2028)

• Pelvic exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others

Preterm Birth And PROM Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Preterm Birth And PROM Testing Market

• Qiagen N.V.
• Hologic, Inc.
• Cooper Surgical Inc.
• Abbott
• Medixbiochemica
• Sera prognostics
• Clinical Innovations, LLC
• Biosynex
• NX Prenatal, Inc.
• IQ Products

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Diagnostics Market Forecasted to Grow at Steady Pace During 2021-2028: Grand View Research Inc.

 Veterinary Diagnostics Market Growth & Trends

The global veterinary diagnostics market size is expected to reach USD 14.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.5% from 2021 to 2028. The growing incidence of zoonotic and foodborne diseases is expected to drive the market over the forecast period. Moreover increasing companion ownership in developing countries is another factor propelling the market.

On a global level, animal product consumption is witnessing a surge. This is supported by increasing human population, per capita income, and animal health awareness in the developing nations. Due to all these elements, the global demand for animal diagnostics has pushed up. The In-vitro (IVD) test kits and analyzers are rapidly filling the market. Apart from that, there is growth observed in the point of care treatments for animals as it provides convenience for the animals and their caretakers. Moreover, the shift towards advanced test techniques such as immune and molecular diagnostics, hematology, and nanotechnology which are quick and efficient in producing the results is further propelling market growth.

Request a free sample copy or view report summary: Veterinary Diagnostics Market Report

Veterinary Diagnostics Market Report Highlights

• The consumables segment held the largest revenue share in 2020 owing to increased usage of consumables in point of care diagnostics
• Under the species segment, canine held the major revenue share in 2020 followed by feline and porcine. The growth can be attributed to increasing healthcare expenditure and growing companion ownership
• The pathology segment held the largest revenue share in 2020 owing to increasing demand for diagnostic consumables and instruments utilized during laboratory testing and the growing volume of pathology tests performed for production animals, avians, and pets
• The non-infectious diseases segment accounted for the largest revenue share in the diseases segment in 2020. But the number of hereditary, congenital, structural, and functional diseases in livestock and companion animals is increasing worldwide
• The point of care segment is expected to show the fastest growth over the coming years. This growth is due to rapidity, efficiency, and user convenience offered by point of care testing
• Asia Pacific is expected to emerge as the fastest-growing region in this market space. Moreover, the U.S. is observed to have the highest number of companies dealing in this space, which in turn, has contributed to the largest share of the market in North America in 2020
• The global meat production is also expected to rise tremendously due to an increase in the per capita income of people in emerging nations, the need for animal protein, and escalating human population
• The upcoming tools and techniques in veterinary diagnostics space are nucleic acid, non-PCR techniques, biosensors, fluorescence polarization technology, whole genome sequencing (WGS), biomarkers, nanotechnology, digitalization and big data use, wearables and apps such as Vet on Demand, Treat, Pet life, and Pet+Pixie

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-diagnostics-market

Veterinary Diagnostics Market Segmentation

Grand View Research has segmented the global veterinary diagnostics market on the basis of product, species, testing category, disease type, end use, and region:

Veterinary Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2028)

• Consumables, Reagents & Kits
• Instruments & Devices

Veterinary Diagnostics Species Outlook (Revenue, USD Million, 2016 - 2028)

• Cattle
• Canine
• Feline
• Caprine
• Equine
• Ovine
• Porcine
• Avian
• Others

Veterinary Diagnostics Testing Category Outlook (Revenue, USD Million, 2016 - 2028)

• Analytical Services
• Diagnostic Imaging
• Bacteriology
• Pathology
• Molecular Diagnostics
• Immunoassays
• Parasitology
• Serology
• Virology

Veterinary Diagnostics Disease Type Outlook (Revenue, USD Million, 2016 - 2028)

• Infectious Diseases
• Non-Infectious Diseases
• Hereditary, Congenital and Acquired Diseases
• General Ailments
• Structural and Functional Diseases

Veterinary Diagnostics End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Laboratories
• Veterinary Hospitals and Clinics
• Point-Of-Care/In-House Testing
• Research Institutes and Universities

Veterinary Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Veterinary Diagnostics Market

• Zoetis
• Heska Corporation
• IDEXX Laboratories Inc.
• Agrolabo S.p.A
• IDvet
• Virbac
• Thermo Fisher Scientific Inc.
• Neogen Corporation
• Covetrus
• iM3Vet Pty Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Lysis & Disruption Market is Likely To Touch USD 8.37 Billion by 2028: Grand View Research Inc.

 Cell Lysis & Disruption Market Growth & Trends

The global cell lysis & disruption market size is expected to reach USD 8.37 billion by 2028, registering a CAGR of 9.35% over the forecast period, according to a new report by Grand View Research, Inc. The anticipated revenue growth is attributed to accelerating the adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products. Technological developments in procedures involved in releasing cellular organelles have paved the way for the higher adoption of cell disruption methods.

As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the market. In addition, advancements in the field of proteomics, metabolomics, and personalized medicine are expected to fuel progressive changes in this sector. However, the high costs of equipment coupled with the dearth of skilled professionals are expected to restrain revenue generation to a certain extent. The restraint can be addressed as the government organizations are releasing substantial funds to support development in the biotechnology sector.

Enzymatic lysis, owing to higher biological specificity, is likely to register the fastest CAGR over the forecast period. Manufacturers are embracing the trend of providing synthetic enzymes and pre-formulated kits, which can be used for the extraction and purification of proteins, DNA, and RNA. Sonication instruments in the products available are expected to witness lucrative growth due to higher adoption rates as a result of the reliability on these instruments. Factors attributing to this reliability include complete control allowed on parameters and negligible maintenance.

Among the physical methods, the high product yield obtained by sonication of the liquid sample is attributed to the larger revenue share of the ultrasonic homogenization method/technique. Asia Pacific will be the fastest-growing regional market from 2021 to 20285 due to lucrative opportunities offered by emerging nations, which has attracted investments from global firms in the region. Key companies are engaged in new product development and strategic alliances to maintain their market share.

Request a free sample copy or view report summary: Cell Lysis & Disruption Market Report

Cell Lysis & Disruption Market Report Highlights

• A rise in the development of biologics has subsequently led to high demand for better bioprocess solutions
• The advantages offered by reagent-based methods for isolation of biological products is attributive to the largest share of the segment in 2020
• The advantages include an unaltered biological activity of the sample of interest and ideal compatibility with the laboratory reagents
• Therefore, key players have developed different detergent-based solutions and buffers, to provide the best possible results for particular tissue types
• Mammalian cell culture systems have grabbed substantial attention among biopharmaceutical manufacturers, thus leading to higher demand for cell lysis protocols for the same
• Pharmaceutical & biotechnology companies accounted for the largest share as a result of the growing demand for biopharmaceutical products
• Substantial research in the development of nucleic-acid derived products is expected to drive progress in this application in the coming years

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-lysis-disruption-market

Cell Lysis & Disruption Market Segmentation

Grand View Research has segmented the global cell lysis & disruption market on the basis of technique, product, cell type, application, end use, and region:

Cell Lysis & Disruption Technique Outlook (Revenue, USD Million, 2018 - 2028)

• Reagent-based
  • Detergent
  • Enzymatic
• Physical Disruption
  • Mechanical Homogenization
  • Ultrasonic Homogenization
  • Pressure Homogenization
  • Temperature Treatments

Cell Lysis & Disruption Product Outlook (Revenue, USD Million, 2018 - 2028)

• Instruments
  • High-pressure Homogenizers
  • Sonicator
  • French Press
  • Microfluidizer
  • Bead Mill
  • Other Instruments
• Reagents & Consumables
  • Enzymes
  • Detergent Solutions
    • Ionic detergent
    • Nonionic detergent
    • Zwitterionic detergent
  • Kits & Reagents

Cell Lysis & Disruption Cell Type Outlook (Revenue, USD Million, 2018 - 2028)

• Mammalian cells
• Bacterial cells
• Yeast/Algae/Fungi
• Plant cells

Cell Lysis & Disruption Application Outlook (Revenue, USD Million, 2018 - 2028)

• Protein Isolation
• Downstream Processing
• Cell Organelle Isolation
• Nucleic Acid Isolation

Cell Lysis & Disruption End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Academic & Research Institutes
• Hospitals & Diagnostic Labs
• Cell Banks
• Pharmaceutical & Biotechnology Companies

Cell Lysis & Disruption Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Cell Lysis & Disruption Market

• Merck KGaA
• Hoffmann-La Roche Ltd.
• Qiagen NV
• Becton Dickinson & Company (BD)
• Danaher Corp.
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec GmbH
• Claremont BioSolutions, LLC
• Microfluidics International Corp.
• Parr Instrument Company
• BioVision, Inc.
• Covaris, Inc.
• Qsonica LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Intravenous Immunoglobulin Market Trends, Company Share, Industry Growth And Future Scope: Grand View Research Inc.

 U.S. Intravenous Immunoglobulin Market Growth & Trends

The U.S. intravenous immunoglobulin market size is expected to reach USD 10.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2021 to 2028. Robust pipeline, approval and launch of novel products, and increasing government initiatives are expected to be the major factors driving the market.

Robust pipeline and increasing approvals and launches of novel products are anticipated to support the market growth over the forecast period. For instance, in April 2019, U.S.-based ADMA Biologics, Inc. received U.S. FDA approval for its new drug Asceniv. It is an IVIG drug indicated for the treatment of primary humoral immunodeficiency disease. Similarly, in December 2019, CSL Behring announced receiving orphan drug exclusivity for Hizentra from the U.S. FDA to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). In another instance, in February 2021, Biotest AG announced that it was the first in Germany to manufacture an investigational hyper immunoglobulin from plasma protein for the COVID-19 treatment.

Furthermore, increasing initiatives by various government organizations to boost the development of novel products are expected to support market growth over the forecast period. For instance, in January 2018, the National Institutes of Health (NIH) awarded a grant of USD 3 million to the U.S.-based GigaGen Inc. to develop novel recombinant intravenous immunoglobulin for patients with primary immunodeficiency diseases.

However, the manufacturing of IVIG requires a well-developed production facility and high capital investments, thereby leading to the high cost of the final product. Hence, this factor is anticipated to restrain the market growth. In addition, IVIG products undergo stringent regulations pertaining to safety and handling, which is another factor expected to impede the market growth. For instance, in 2018, the U.S. FDA delayed the approval of GC Pharma’s intravenous immunoglobulin product and demanded additional data related to the drug’s manufacturing process.

Request a free sample copy or view report summary: U.S. Intravenous Immunoglobulin Market Report

U.S. Intravenous Immunoglobulin Market Report Highlights

• By application, immunodeficiency diseases dominated the market in 2020 owing to the rising number of cases and the growing adoption of IVIG for the treatment of these diseases
• The multifocal motor neuropathy application segment is expected to register the fastest growth rate over the forecast period due to the high effectivity of IVIG in its treatment
• Based on distribution channel, hospital pharmacy held the largest share in 2020 owing to a large number of hospital pharmacies and the easy availability of products in the hospitals
• Market leaders are involved in the development of new plasma collection centers and other collaborative strategies to expand their geographical reach and widen their product portfolio

Access Press Release@ https://www.grandviewresearch.com/press-release/us-intravenous-immunoglobulin-ivig-market-analysis

U.S. Intravenous Immunoglobulin Market Segmentation

Grand View Research has segmented the U.S. intravenous immunoglobulin market on the basis of application and distribution channel:

U.S. IVIG Application Outlook (Revenue, USD Million, 2016 - 2028)

• Hypogammaglobulinemia
• CIDP
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-barre Syndrome
• Others

U.S. IVIG Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Pharmacy
• Specialty Pharmacy
• Others

List of Key Players of U.S. Intravenous Immunoglobulin (IVIG) Market

• Biotest AG
• Octapharma AG
• LFB Biotechnologies S.A.S
• China Biologics Products Holdings, Inc.
• Grifols, S.A.
• Kedrion Biopharma, Inc.
• CSL Behring
• McKesson Corporation
• Takeda Pharmaceutical Company Limited
• Bio Products Laboratory Ltd.
• Pfizer, Inc.
• ADMA Biologics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Research Antibodies Market Latest Innovations, Drivers and Industry Key Events 2021 – 2028: Grand View Research Inc.

 Research Antibodies Market Growth & Trends

The global research antibodies market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Major market drivers include a rise in R&D initiatives undertaken by biopharmaceutical and biotechnology companies and government bodies, an increase in neurobiology and stem cell research, availability of technologically advanced products, and strategic collaborations among various key players.

An increase in the usage of research antibodies to develop therapies for various chronic and infectious diseases, including COVID-19, is anticipated to boost the market growth during the forecast period. For instance, in June 2019, the Institute of Life Sciences (ILS, India) developed antibodies against chikungunya viral infection. These antibody structures were developed to aid scientists in understanding various aspects of virus pathogenesis entailing further research on antiviral therapies. Growing government funds and initiatives for R&D are anticipated to fuel market growth during the forecast period in the Asia Pacific region. According to the 2018-2019 Australian Budget, approximately USD 94 million was estimated for four years for new industry collaborations, research as well as new biomedical and medical programs.

Additionally, a rise in funds invested by pharmaceutical and biotechnology companies to enhance proteomics and genomics research is expected to boost market growth. For instance, in 2017, Biognosys Inc. raised USD 5 million in funds to increase, advance, and develop next-generation proteomics products and workflow for high throughput and high content protein analysis. The rise in the number of major players investing in advanced technologies and collaborating with other key players is also anticipated to impact market potential positively in the near future. For instance, Abcellera uses technologically advanced techniques to test antibodies from single B cells, map and screen natural immune responses, and discover novel antibody therapies. The company has also partnered with Sanofi, Pfizer, Teva, Merck, and GSK to discover and develop new antibody-based therapies. Moreover, the launch of novel antibody structures for the diagnosis of various diseases is also a major factor expected to boost market growth. For instance, in August 2018, BioGenex launched a range of new antibodies for its use in cancer immunohistochemistry.

Request a free sample copy or view report summary: Research Antibodies Market Report

Research Antibodies Market Report Highlights

• In 2020, primary antibodies held a dominant share in terms of revenue in the product segment owing to greater specificity, therefore, leading to increase adoption in R&D activities        
• Monoclonal antibodiescaptured a substantial share in 2020, as they offer higher sensitivity for the detection of antigens and also showcase efficient staining properties for various applications
• The neurobiology segment is expected to witness exponential growth over the forecast period owing to the increasing prevalence of diseases that have limited treatment options and the rise in R&D activities by biotech companies and academic institutes
• Pharmaceutical and biotechnology companies were dominant in terms of revenue amongst all end-users in 2020, owing to the increased adoption of research antibodies in drug development and discovery
• In 2020, North America accounted for the substantial revenue share which is attributable to the high presence of many biotechnologies as well as biopharmaceutical manufacturers, research academies, and laboratories

Access Press Release@ https://www.grandviewresearch.com/press-release/global-research-antibodies-market

Research Antibodies Market Segmentation

Grand View Research has segmented the global research antibodies market on the basis of product, type, technology, source, application, end-use, and region:

Research Antibodies Product Outlook (Revenue, USD Million, 2018 - 2028)

• Primary
• Secondary

Research Antibodies Type Outlook (Revenue, USD Million, 2018 - 2028)

• Monoclonal Antibodies
• Polyclonal Antibodies

Research Antibodies Technology Outlook (Revenue, USD Million, 2018 - 2028)

• Immunohistochemistry
• Immunofluorescence
• Western Blotting
• Flow Cytometry
• Immunoprecipitation
• ELISA
• Other Technologies

Research Antibodies Source Outlook (Revenue, USD Million, 2018 - 2028)

• Mouse
• Rabbit
• Goat
• Other Sources

Research Antibodies Application Outlook (Revenue, USD Million, 2018 - 2028)

• Infectious Diseases
• Immunology
• Oncology
• Stem Cells
• Neurobiology
• Other Applications

Research Antibodies End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies

Research Antibodies Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Australia
  • India
  • Japan
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Research Antibodies Market

• Abcam Plc
• Bio-rad Laboratories
• Becton Dickinson & Company
• Merck Millipore
• Lonza Group
• Thermo Fisher Scientific, Inc.
• Cell Signalling Technology, Inc.
• Hoffmann La Roche Ltd.
• Agilent Technologies
• Perkinelmer, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.